enter
cytoplasm
membran
thu
increas
ph
aciddepend
subcellular
function
inhibit
consequ
antigen
process
macrophag
impair
due
increas
ph
cq
hcq
inhibit
proinflammatori
cytokin
like
intracellular
tolllik
receptor
tlr
downregul
tlrmediat
signal
transduct
anoth
aspect
antimalari
reduct
autoimmun
upregul
apoptosi
elimin
autoreact
lymphocyt
hcq
cq
shown
show
antivir
activ
inhibit
receptor
bind
membran
fusion
play
role
entri
coronavirus
cell
moreov
replic
viru
block
due
chang
ph
requir
lysosom
enzym
activ
due
mechan
action
drug
overactiv
immun
system
trigger
may
suppress
progress
sever
diseas
may
slow
addit
suggest
cq
hcq
could
potenti
benefici
also
low
cost
wide
use
worldwid
includ
rheumat
diseas
lower
side
effect
profil
inhibit
viru
cell
treat
cq
infect
suggest
cq
prophylact
therapeut
advantag
howev
evid
prophylact
use
guidelin
cq
also
use
worldwid
malaria
treatment
prophylaxi
year
cq
shown
inhibit
coronaviru
replic
malaria
one
devast
parasit
diseas
face
human
across
world
remain
crucial
public
health
challeng
mostli
poor
tropic
subtrop
area
world
especi
africa
asia
europ
america
took
initi
erad
malaria
across
world
reduc
malaria
transmiss
even
elimin
mani
associ
taken
remark
step
countri
elimin
malaria
past
centuri
date
mani
countri
develop
nation
elimin
goal
region
network
elimin
malaria
elimin
strategi
implement
major
strategi
prevent
malaria
mainli
reli
vector
control
manag
reduc
risk
vectorhuman
contact
diseas
manag
earli
detect
method
chemoprevent
aryl
amino
alcohol
compound
quinin
chloroquin
lumefantrin
etc
antifol
compound
pyrimethamin
proguanil
etc
artemisinin
compound
artemisinin
artesun
etc
common
antimalari
drug
malaria
treatment
amodiaquin
cq
primaquin
pq
main
compon
presumpt
plasmodium
falciparum
plasmodium
vivax
malaria
treatment
cq
main
compon
plasmodium
falciparum
cq
resist
first
identifi
despit
reduc
use
cq
use
maintain
uncompl
plasmodium
falciparum
malaria
hcq
report
less
activ
less
toxic
plasmodium
falciparum
malaria
cq
plasmodium
vivax
treatment
recommend
continu
use
cq
mgkg
day
pq
mgkg
day
p
falciparum
treatment
oral
quinin
qn
tetracyclin
doxycyclin
recommend
treatment
cq
sp
fail
howev
singl
dose
cq
longer
recommend
presumpt
treatment
malari
drug
use
trend
chang
cq
sp
act
african
countri
follow
year
long
year
reduct
cq
use
caus
reduct
drug
pressur
lead
return
suscept
parasit
popul
follow
use
cq
cq
still
commonli
use
treatment
febril
ill
children
long
term
chemoprophylaxi
mgkg
bodi
weight
mg
weekli
mefloquin
recommend
continu
two
week
four
week
departur
area
today
cq
recommend
p
falciparum
treatment
africa
howev
cq
use
persist
mani
year
especi
privat
sector
sinc
cq
sp
cheaper
act
avail
marketplac
wide
consequ
although
number
test
health
data
carri
africa
especi
malariaintens
region
clear
situat
becom
clear
analysi
postpandem
period
perhap
thought
use
hcq
provid
protect
